Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeros Tech Regulatory News (XSG)

Share Price Information for Xeros Tech (XSG)

Share Price is delayed by 15 minutes
Get Live Data
1.425    -0.075 (-5.00%)
Bid:
1.35
Ask:
1.50
Spread: 0.15 (11.111%)
Market Cap: £12.28m
XSG Live PriceLast checked at - London Stock Exchange

Intraday Xeros Tech Share Chart

Directorate Change

12 Dec 2022 07:00

RNS Number : 2862J
Xeros Technology Group plc
12 December 2022
 

 

 

This announcement contains inside information

12 December 2022

 

Xeros Technology Group plc

 

('Xeros' or the 'Company' or the 'Group')

 

 Directorate Change

 

Xeros Technology Group plc (AIM: XSG), the creator of technologies that reduce the impact of clothing on the planet, today announces that Paul Denney, Chief Financial Officer and Company Secretary, will step down from the Board on 28 February 2023 to pursue new opportunities outside the Company.

 

A search process for his replacement will commence immediately and Paul is committed to supporting an orderly handover.

 

As part of the above arrangements and in recognition of his contribution to the business over his six years of service, his status as a "good leaver" under the Company's EMI Share Option Scheme ("EMI Scheme") and Unapproved Share Option Scheme ("Unapproved Scheme") (together, the "Schemes") and to properly incentivise Paul during the transition period, the Remuneration Committee has determined:

 

1) to allow Mr Denney to keep 1,055,182 unapproved options granted to him in November 2022 under the terms of the Unapproved Scheme; and

2) to waive all vesting criteria attaching to those options.

 

Discretion to do so is permitted under the terms of the Schemes. All other options held by Mr Denney will lapse according to the terms of the schemes.

 

Neil Austin, Chief Executive Officer of Xeros said:

 

"Through his leadership of the finance function and as a Board member and Company Secretary, Paul has played an important role in the evolution of the business over the past six years and through challenging economic conditions. On the eve of the Company's next chapter, he leaves us well placed to continue the commercialisation of our portfolio of technologies.

 

"On behalf of everyone at Xeros I would like to thank Paul for his significant contribution."

  

 

Enquiries:

Xeros Technology Group plc

Neil Austin, Chief Executive Officer

Paul Denney, Chief Financial Officer

Tel: 0114 321 6328

 

finnCap Limited (Nominated Adviser and Broker)

Julian Blunt/Teddy Whiley, Corporate Finance

Andrew Burdis/Sunila de Silva, ECM

 

Yellow Jersey PR

Sarah Hollins/Lilian Filips/Annabelle Wills

Tel: 020 7220 0570

 

 

 

Tel: 020 3004 9512

 

 

 

Notes to Editors

 

POWERED BY SCIENCE, XEROS CREATE TECHNOLOGIES ENGINEERED FOR THE FUTURE

 

Born out of textile research and advancing new standards of performance and responsibility, Xeros' technologies revolutionise the way we make and clean our clothes, conserving water and preventing waste. Designed to impact industries and people on a global scale, Xeros transform the performance, impact and economics of the fashion and washing machine industry. 

 

Xeros enable the scaling of their innovations and impact by licencing their intellectual property to partners across the globe. Their work has, to date, created 38 patent families.

 

Xeros' technologies are already in use in major global industries, including commercial and home laundry and garment manufacture. So far, these technologies have saved millions of litres of water and could prevent billions of microfibres from ending in our oceans.

TO THE POWER OF CHANGE  

xerostech.com

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRBDDLUGDGDC
Date   Source Headline
28th Apr 20267:00 amRNSFull Year Results 2025
21st Apr 20267:00 amRNSNotice of Results and Online Presentation
5th Mar 20267:00 amRNSPurchase Order ahead of European Launch of XF3
11th Feb 202610:39 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSBoard Change
27th Jan 20267:00 amRNSTrading Update
7th Jan 20262:52 pmRNSTR-1 First Equity
2nd Jan 202611:46 amRNSBlock listing Interim Review
11th Dec 20251:06 pmRNSTR-1 Entrepreneurs Fund
2nd Dec 20254:48 pmRNSTR-1 Lombard Odier
2nd Dec 20252:26 pmRNSTR-1 Dowgate
2nd Dec 202511:10 amRNSTR-1 Maven
28th Nov 202511:02 amRNSResults of General Meeting and Director Dealings
27th Nov 202512:28 pmRNSResult of Follow-on Subscription and TVR
26th Nov 20254:44 pmRNSTR-1 Spreadex
11th Nov 20251:14 pmRNSResult of Retail Offer
7th Nov 202510:15 amRNSResult of Fundraising
7th Nov 20257:00 amRNSRetail Offer
6th Nov 20256:32 pmRNSProposed Fundraise
24th Oct 20253:07 pmRNSBlock listing Interim Review
14th Oct 20255:11 pmRNSTR-1 Maven
10th Oct 20255:20 pmRNSTR-1 Dowgate
9th Oct 20252:05 pmRNSTR-1 Spreadex
9th Oct 202511:04 amRNSTR-1 First Equity
8th Oct 20257:00 amRNSBreakthrough Launch Agreement
1st Oct 20252:08 pmRNS-RInterim Results 2025 Online Presentation
30th Sep 20257:00 amRNSInterim Results 2025
15th Sep 20256:07 pmRNSTR-1 Dowgate
12th Sep 20251:03 pmRNSTR-1 Dowgate
5th Aug 202512:13 pmRNSTR-1 First Equity
7th Jul 20252:33 pmRNSTR-1 Spreadex
19th Jun 20251:46 pmRNSResult of AGM
5th Jun 202510:11 amRNSCorrection - Application for Block Listing
4th Jun 202510:00 amRNSApplication for Block Listing
29th May 20252:43 pmRNSTR-1 Spreadex
28th May 20253:32 pmRNSTR-1 First Equity
28th May 20252:31 pmRNSTR-1 Spreadex
27th May 20252:37 pmRNSNotice of AGM and Posting of Annual Report
20th May 20257:00 amRNSFull Year Results 2024 and Trading Update
9th May 202511:08 amRNSTR-1 Spreadex
7th May 20257:00 amRNSNotice of Results and Online Presentation
6th May 202510:10 amRNSTR-1 Maven Capital
2nd May 20254:00 pmRNSTR-1 Spreadex
1st May 20254:35 pmRNSTR-1 - First Equity
31st Mar 20257:00 amRNSGrant of Options
7th Mar 202512:56 pmRNSTR-1 Spreadex
17th Feb 20252:18 pmRNSTR-1 Spreadex
17th Feb 202511:07 amRNSTR-1 First Equity
13th Feb 202512:05 pmRNSTR-1 Spreadex
13th Feb 202510:21 amRNSTR-1 First Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.